You are here: Industry Insights > lung cancer

News List

Launch of largest ever UK lung cancer screening study pharmatimes
December 13, 2018
The largest ever lung cancer screening project undertaken in the UK has launched in London, aiming to detect lung cancer early among at-risk citizens.
FDA green lights Pfizer’s Lorbrena for aggressive lung cancer pharmaphorum
December 12, 2018
Pfizer’s drug Lorbrena (lorlatinib) can be used to treat certain types of advanced lung cancer.The US Food and Drug Administration (FDA) approved the treatment.....
Roche’s lung cancer combo treatment wins FDA approval expressbpd
December 11, 2018
The approval was based on results from a late-stage study, which showed the Tecentriq regimen helped patients with metastatic non-squamous non-small cell lung cancer (NSCLC)
Roche’s Tecentriq wins key lung cancer approval. Its prize? A showdown with formidable Merck fiercepharma
December 10, 2018
Merck’s Keytruda finally has some immuno-oncology competition in the previously untreated non-small cell lung cancer market, courtesy of Roche and its freshly minted Tecentriq-Avastin combo.
AbbVie suffers fresh setback with lung cancer drug Rova-T pharmaphorum
December 10, 2018
AbbVie has suffered a further setback with its oncology drug Rova-T, after early data from a lung cancer trial suggested that patients were living longer when treated with standard therapy.
Roche’s Tecentriq gets FDA priority review to treat small cell lung cancer pharmaceutical-technology
December 10, 2018
The US Food and Drug Administration (FDA) has granted priority review for Roche’s Tecentriq (atezolizumab) in combination with chemotherapy for treating extensive-stage small cell lung cancer (ES – SCLC).....
FDA grants priority review to Roche's Tecentriq in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cancer worldpharmanews
December 10, 2018
Roche announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq®
Roche's marketing application for Tecentriq in small cell lung cancer gets FDA priority review firstwordpharma
December 05, 2018
Roche said Wednesday that the FDA granted priority review to a marketing application seeking approval of Tecentriq (atezolizumab), in combination with chemotherapy, for the initial treatment of people with extensive-stage small cell lung cancer (SCLC). Th
Biocartis, AstraZeneca aim faster lung cancer biomarker results biospectrumasia
December 05, 2018
Many lung cancers are driven by mutations in the epidermal growth factor receptor (EGFR), which occur in 10-15% of NSCLC patients in the US and the EU, and 30-40% of NSCLC patients in Asia.
Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb join forces to map out lung cancer immunology firstwordpharma
December 02, 2018
A ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments will be created as part of a collaboration between Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb, announc

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page